Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drug Safety
Metadata
Title
Risk-Benefit Assessment of Therapies for Mycobacterium avium Complex Infections
Author
Dr David E. Griffith
Publication date
01-08-1999
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 2/1999
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199921020-00006

Other articles of this Issue 2/1999

Drug Safety 2/1999 Go to the issue

Leading Article

Use of Phenothiazines as Sedatives in Children

Review Article

Drug-Induced Cognition Disorders in the Elderly

Review Article

Drug-Induced Lymphopenia

Current Opinion

Biological Interpretation of Relative Risk

Review Article

Potential Interactions of the Extended-Spectrum Fluoroquinolones with the CNS